Publications by authors named "Barbara Bumstead"

Claim this Profile
D
Does cognitive performance explain the gap between physiological and perceived fall-risk in people with multiple sclerosis?
Tobia Zanotto, Danya Pradeep Kumar, Daniel Golan, Jeffrey Wilken, Glen M Doniger, Barbara Bumstead

Mult Scler Relat Disord· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysomnography parameters in a large cohort of people with multiple sclerosis.
Munther Queisi, Veronica Cipriani, Daniel Golan, Christy El Ghorayeb, Myassar Zarif, Barbara Bumstead

Sleep Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the relationship between manual dexterity and cognition in people with multiple sclerosis: 9-hole peg and multiple cognitive functions.
Rinu Abraham, Amiya Waldman-Levi, Marissa A Barrera, Hans Bogaardt, Daniel Golan, Barbara Bumstead

Mult Scler Relat Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel Fumarate.
Mark Gudesblatt, Barbara Bumstead, Marijean Buhse, Myassar Zarif, Sarah A Morrow

Adv Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study.
Barry A Singer, Sibyl Wray, Mark Gudesblatt, Barbara Bumstead, Tjalf Ziemssen

Neurol Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the effect of dimethyl fumarate on subclinical biomarkers in a real-world patient cohort.
Stephen Krieger, Myassar Zarif, Barbara Bumstead, Marijean Buhse, Olivia Kaczmarek

J Neuroimmunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters.
Munther Queisi, Hrayr Attarian, Veronica P Cipriani, Saria Azzi, Olivia Kaczmarek, Barbara Bumstead

Int J MS Care· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis.
Thomas J Covey, Daniel Golan, Robert Sergott, Jeffrey Wilken, Myassar Zarif, Barbara Bumstead

J Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumab.
Mark Gudesblatt, Myassar Zarif, Barbara Bumstead, Marijean Buhse, Olivia Kaczmarek

Mult Scler J Exp Transl Clin· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis and quality of life: The role of cognitive impairment on quality of life in people with multiple sclerosis.
Catherine Bergmann, Shenira Becker, Adreanna Watts, Cynthia Sullivan, Jeffrey Wilken, Barbara Bumstead

Mult Scler Relat Disord· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?
Hans Bogaardt, Daniel Golan, Marissa A Barrera, Stacie Attrill, Olivia Kaczmarek, Barbara Bumstead

Mult Scler Relat Disord· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The moderating roles of self-efficacy and depression in dual-task walking in multiple sclerosis: A test of self-awareness theory.
Charles Van Liew, Mark Gudesblatt, Thomas J Covey, Jeffrey Wilken, Daniel Golan, Barbara Bumstead

J Int Neuropsychol Soc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and clinicians.
Daija A Jackson, Rachel Nicholson, Catherine Bergmann, Jeffrey Wilken, Olivia Kaczmarek, Barbara Bumstead

Mult Scler Relat Disord· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual differences in visual evoked potential latency are associated with variance in brain tissue volume in people with multiple sclerosis: An analysis of brain function-structure correlates.
Thomas J Covey, Daniel Golan, Myassar Zarif, Barbara Bumstead, Marijean Buhse

Mult Scler Relat Disord· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged visual evoked potential latency predicts longitudinal worsening of fatigue in people with multiple sclerosis.
Thomas J Covey, Daniel Golan, Glen M Doniger, Robert Sergott, Myassar Zarif, Barbara Bumstead

Mult Scler Relat Disord· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal assessment of the relationship between visual evoked potentials and cognitive performance in multiple sclerosis.
Thomas J Covey, Daniel Golan, Glen M Doniger, Robert Sergott, Myassar Zarif, Barbara Bumstead

Clin Neurophysiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient.
Justin M Leach, Gary Cutter, Daniel Golan, Glen Doniger, Myassar Zarif, Barbara Bumstead

Mult Scler Relat Disord· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability of objective gait measures across the expanded disability status scale in people living with multiple sclerosis: A cross-sectional retrospective analysis.
Tobia Zanotto, Jacob J Sosnoff, Edward Ofori, Daniel Golan, Myassar Zarif, Barbara Bumstead

Mult Scler Relat Disord· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between cognitive impairment, cognitive fatigue, and visual evoked potential latency in people with multiple sclerosis.
Thomas J Covey, Daniel Golan, Glen M Doniger, Robert Sergott, Myassar Zarif, Barbara Bumstead

Mult Scler Relat Disord· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual evoked potential latency predicts cognitive function in people with multiple sclerosis.
Thomas J Covey, Daniel Golan, Glen M Doniger, Robert Sergott, Myassar Zarif, Barbara Bumstead

J Neurol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between MRI brain volumes and computerized cognitive scores of people with multiple sclerosis.
Daniel Golan, Glen M Doniger, Jared Srinivasan, Diana M Sima, Myassar Zarif, Barbara Bumstead

Brain Cogn· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis.
Daniel Golan, Jeffrey Wilken, Glen M Doniger, Timothy Fratto, Robert Kane, Barbara Bumstead

Mult Scler Relat Disord· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis.
Mark Gudesblatt, Karl Wissemann, Myassar Zarif, Barbara Bumstead, Lori Fafard

CNS Drugs· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis.
Mark Gudesblatt, Karl Wissemann, Myassar Zarif, Barbara Bumstead, Lori Fafard

CNS Drugs· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis.
Daniel Golan, Glen M Doniger, Karl Wissemann, Myassar Zarif, Barbara Bumstead

Mult Scler· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis